We carried out a genome-wide association study of IgA nephropathy, a major cause of kidney
failure worldwide. We studied 1,194 cases and 902 controls of Chinese Han ancestry, with …

We performed a genome-wide association study (GWAS) of IgA nephropathy (IgAN), the most
common form of glomerulonephritis, with discovery and follow-up in 20,612 individuals of …

IgA nephropathy (IgAN) is a progressive form of kidney disease defined by glomerular
deposition of IgA. Here we performed a genome-wide association study of 10,146 kidney-biopsy-…

Background A cyclic corticosteroid-cyclophosphamide regimen is the first-line therapy for
membranous nephropathy. Compared with this regimen, rituximab therapy might have a more …

Objective— To better understand the role of lecithin:cholesterol acyltransferase (LCAT) in
lipoprotein metabolism through the genetic and biochemical characterization of families …

Background— Mutations in the LCAT gene cause lecithin:cholesterol acyltransferase (LCAT)
deficiency, a very rare metabolic disorder with 2 hypoalphalipoproteinemia syndromes: …

Background & aims In hospitalized patients malnutrition is a risk factor for adverse clinical
outcomes. The Nutritional Risk Screening 2002 (NRS-2002) represents a quick and simple …

Background In southern Europe, the risk of cancer in patients with end-stage kidney disease
receiving dialysis has not been well quantified. The aim of this study was to assess the …

Familial LCAT deficiency (FLD) is a rare genetic disorder of HDL metabolism, caused by
loss-of-function mutations in the LCAT gene and characterized by a variety of symptoms …

Background Kidney failure is the major cause of morbidity and mortality in familial lecithin:cholesterol
acyltransferase deficiency (FLD), a rare inherited lipid disorder with no cure. …